When prescribed for weight loss, Wegovy and other GLP-1 medications are generally intended for people with: Obesity, defined as a body mass index (BMI) of 30 or more Overweight, defined as a BMI of 27 or more, and a weight-related health problem (e.g., high blood pressure, high cholesterol, type 2 diabetes) Your prescribing doctor may also ask about your previous experiences with weight loss
our ability to raise funding in the future, as needed, and the terms of such funding, including potential dilution caused thereby
This is especially valuable if you're considering the Precision Peptide Genetic Test, which can reveal genetic predispositions in your GLP-1 receptor pathway and help optimize your medication choice or dose trajectory
Seek immediate medical attention for loss of consciousness, chest pain, severe breathlessness, or signs of stroke
Document baseline blood pressure, current antihypertensive medications, and cardiovascular history
Stress regulation